During the past decade, Obudai Egeszsegugyi Centrum conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Obudai Egeszsegugyi Centrum" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "R-Pharm International, LLC" with 2 trials sponsored, "Diamyd Medical AB" with 1 trials sponsored and "Fresenius Kabi SwissBioSim GmbH" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Obudai Egeszsegugyi Centrum" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "EXCELYA Bordeaux" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Obudai Egeszsegugyi Centrum" are "Rheumatoid Arthritis" (2 trials), "Acute Pain" (1 trials), "Atopic Dermatitis" (1 trials), "Autoimmune Diabetes" (1 trials) and "Autoimmune Diseases" (1 trials). Many other conditions were trialed in "Obudai Egeszsegugyi Centrum" in a lesser frequency.

Most popular intervention types in "Obudai Egeszsegugyi Centrum" are "Drug" (11 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Adalimumab 40mg q2w" (1 trials), "BI 1358894" (1 trials), "Colecalciferol 2000 IU" (1 trials) and "FKS518" (1 trials). Other intervention names were less common.

The vast majority of trials in "Obudai Egeszsegugyi Centrum" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Obudai Egeszsegugyi Centrum". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Obudai Egeszsegugyi Centrum, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Obudai Egeszsegugyi Centrum, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".